Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401928
Status:
COMPLETED
Last Update Posted:
2024-05-08
First Post:
2024-05-01
Brief Title:
Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis
Sponsor:
The National Brain Mapping Laboratory NBML
Organization:
The National Brain Mapping Laboratory NBML
Study Overview
Official Title:
Electrical Brain Stimulation for Improving Mental Health and Cognitive Functioning in Patients With Multiple Sclerosis
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Multiple Sclerosis MS is an autoimmune disease associated with physical disability psychological impairment and cognitive dysfunction As a result the disease burden is high and treatment options are limited In this randomized double-blind study the investigators planned to use repeated electrical stimulation and assess mental health-related variables eg quality of life sleep psychological distress and cognitive dysfunction in patients with MS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None